ÂÜÀòÂÒÂ×

Jay is currently Chief Operating Officer at Celularity, a biotech start-up focused on harnessing the power of allogeneic placental cell therapeutics in Immuno-Oncology and other diseases with unmet medical needs.

Jay has close to 30 years of experience in the pharmaceutical and biotechnology industry, covering a broad range of therapeutic areas. He is an accomplished executive who is equally adept at shaping strategy and driving execution and nurturing culture.

Jay held the position of SVP, Global Clinical Research & Development Operations at Celgene Corporation, where he was responsible for leading all Global Clinical R&D Operations in support of Celgene-sponsored trials. At Celgene, Jay was also Director Field Sales; Executive Director Sales and Commercial Operations; Vice President Strategic Operations; Vice President General Manager, Celgene Cellular Therapeutics; and Vice President Business Development. Jay was instrumental in designing and patenting the enhanced S.T.E.P.S. (REMS) managed distribution program in support of THALOMID (thalidomide) and REVLIMID (lenalidomide) commercialization and successor compounds.

Prior to joining Celgene, Jay was with TAP Pharmaceuticals, a joint venture between Abbott Laboratories and Takeda Pharmaceuticals, for seven years, where he held various positions in sales, sales management, and marketing.

Jay holds a B.S Degree in Business Management from Ithaca College.